Dupilumab improves mental health measures in patients with chronic rhinosinusitis and nasal polyposis (CRSwNP)

Conclusion: Dupilumab added to MFNS significantly improves mental health in patients with CRSwNP, as assessed by SF-36 MCS scores.

Source: European Respiratory Journal - November 19, 2018 Category: Respiratory Medicine Authors: Bachert, C., Naclerio, R., Hellings, P., Guillonneau, S., Taniou, C., Maroni, J., Rowe, P., Mannent, L., Amin, N., Kamat, S., Khan, A. Tags: Allergy and immunology Source Type: research